• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Comparison of cytology, chest computed and positron emission tomography findings in malignant pleural effusion from lung cancer.肺癌所致恶性胸腔积液的细胞学、胸部计算机断层扫描及正电子发射断层扫描结果比较
J Thorac Dis. 2018 Dec;10(12):6903-6911. doi: 10.21037/jtd.2018.11.127.
2
Development and validation of the PET-CT score for diagnosis of malignant pleural effusion.开发和验证用于诊断恶性胸腔积液的 PET-CT 评分。
Eur J Nucl Med Mol Imaging. 2019 Jul;46(7):1457-1467. doi: 10.1007/s00259-019-04287-7. Epub 2019 Mar 22.
3
Pleural Uptake Patterns in Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) Scans Improve the Identification of Malignant Pleural Effusions.氟脱氧葡萄糖正电子发射断层扫描(FDG-PET)中胸膜摄取模式有助于提高恶性胸腔积液的识别率。
J Clin Med. 2023 Nov 8;12(22):6977. doi: 10.3390/jcm12226977.
4
Diagnosis of Malignant Pleural Effusion Using CT Scan and Pleural-Fluid Cytology Together. A Preliminary Case-Control Study.CT 扫描与胸腔积液细胞学检查联合用于恶性胸腔积液的诊断。一项初步的病例对照研究。
Anticancer Res. 2020 Feb;40(2):1135-1139. doi: 10.21873/anticanres.14054.
5
Possible Role of Chest Ultrasound in the Assessment of Costo-Phrenic Angle Lesions Prior to Medical Thoracoscopy: A Retrospective Pilot Case Series.胸部超声在医学胸腔镜检查前评估肋膈角病变中的可能作用:一项回顾性试点病例系列研究
Diagnostics (Basel). 2022 Oct 25;12(11):2587. doi: 10.3390/diagnostics12112587.
6
Can PET/CT be used more effectively in pleural effusion evaluation?PET/CT 在胸腔积液评估中能否更有效地使用?
Jpn J Radiol. 2021 Dec;39(12):1186-1194. doi: 10.1007/s11604-021-01155-z. Epub 2021 Jun 24.
7
[Thoracocentesis for the assessment of lung cancer with pleural effusion].[胸腔穿刺术用于评估伴有胸腔积液的肺癌]
Arch Bronconeumol. 2002 Oct;38(10):479-84. doi: 10.1016/s0300-2896(02)75269-1.
8
[Value of PET/MRI in the diagnosis of malignant pleural effusion in comparison with PET/CT].[PET/MRI与PET/CT相比在恶性胸腔积液诊断中的价值]
Zhonghua Yi Xue Za Zhi. 2021 Aug 10;101(30):2363-2369. doi: 10.3760/cma.j.cn112137-20210516-01142.
9
Idiopathic Pleural Effusions: Characteristics and Discrimination From Cytology-Negative Malignant Pleural Effusions.特发性胸腔积液:特征与细胞学阴性恶性胸腔积液的鉴别。
Am J Med Sci. 2020 Sep;360(3):236-242. doi: 10.1016/j.amjms.2020.04.020. Epub 2020 Apr 25.
10
Pleural effusions associated with squamous cell lung carcinoma have a low diagnostic yield and a poor prognosis.与鳞状细胞肺癌相关的胸腔积液诊断率低且预后差。
Transl Lung Cancer Res. 2021 Jun;10(6):2500-2508. doi: 10.21037/tlcr-21-123.

引用本文的文献

1
Computed Tomography-Based Radiomic Nomogram to Predict Occult Pleural Metastasis in Lung Cancer.基于计算机断层扫描的影像组学列线图预测肺癌隐匿性胸膜转移
Curr Oncol. 2025 Apr 11;32(4):223. doi: 10.3390/curroncol32040223.
2
Role of HEG1 and Claudin-4 Immunohistochemistry in the Differential Diagnosis of Lung Adenocarcinoma from Malignant Mesothelioma in Pleural Effusion Cytology.HEG1和Claudin-4免疫组化在胸腔积液细胞学中鉴别肺腺癌与恶性间皮瘤的作用
Turk Patoloji Derg. 2025;41(2):42-50. doi: 10.5146/tjpath.2025.13801.
3
Pleural Uptake Patterns in Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) Scans Improve the Identification of Malignant Pleural Effusions.氟脱氧葡萄糖正电子发射断层扫描(FDG-PET)中胸膜摄取模式有助于提高恶性胸腔积液的识别率。
J Clin Med. 2023 Nov 8;12(22):6977. doi: 10.3390/jcm12226977.
4
Lung Cancer: Spectral and Numerical Differentiation among Benign and Malignant Pleural Effusions Based on the Surface-Enhanced Raman Spectroscopy.肺癌:基于表面增强拉曼光谱的良恶性胸腔积液的光谱和数值鉴别
Biomedicines. 2022 Apr 25;10(5):993. doi: 10.3390/biomedicines10050993.
5
Prognostic role of immune microenvironment in pleural metastases from breast and lung adenocarcinomas.免疫微环境在乳腺和肺腺癌胸膜转移中的预后作用
Ann Transl Med. 2022 Apr;10(8):430. doi: 10.21037/atm-21-6326.
6
Evaluation of pleural fluid cytology for the diagnosis of malignant pleural effusion: a retrospective cohort study.胸腔积液细胞学检查对恶性胸腔积液的诊断价值:一项回顾性队列研究。
Intern Med J. 2022 Jul;52(7):1154-1159. doi: 10.1111/imj.15725. Epub 2022 Apr 7.
7
The Liquid Biopsy for Lung Cancer: State of the Art, Limitations and Future Developments.肺癌的液体活检:现状、局限性与未来发展
Cancers (Basel). 2021 Aug 4;13(16):3923. doi: 10.3390/cancers13163923.
8
Computed Tomography Morphological Classification of Lung Adenocarcinoma and Its Correlation with Epidermal Growth Factor Receptor Mutation Status: A Report of 1075 Cases.肺腺癌的计算机断层扫描形态学分类及其与表皮生长因子受体突变状态的相关性:1075例报告
Int J Gen Med. 2021 Jul 21;14:3687-3698. doi: 10.2147/IJGM.S316344. eCollection 2021.
9
Current Applications for Nuclear Medicine Imaging in Pulmonary Disease.核医学成像在肺部疾病中的当前应用
Curr Pulmonol Rep. 2020;9(3):82-95. doi: 10.1007/s13665-020-00251-1. Epub 2020 Jul 22.
10
Gene variant profiles and tumor metabolic activity as measured by FOXM1 expression and glucose uptake in lung adenocarcinoma.通过肺腺癌中FOXM1表达和葡萄糖摄取所测量的基因变异谱和肿瘤代谢活性。
J Pathol Transl Med. 2020 May;54(3):237-245. doi: 10.4132/jptm.2020.02.08. Epub 2020 Mar 4.

本文引用的文献

1
Investigating unilateral pleural effusions: the role of cytology.探讨单侧胸腔积液:细胞学的作用。
Eur Respir J. 2018 Nov 8;52(5). doi: 10.1183/13993003.01254-2018. Print 2018 Nov.
2
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.早期和局部晚期非小细胞肺癌(NSCLC):ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2017 Jul 1;28(suppl_4):iv1-iv21. doi: 10.1093/annonc/mdx222.
3
Positive pleural cytology is an indicator for visceral pleural invasion in metastatic pleural effusions.阳性胸膜细胞学检查是转移性胸腔积液中脏层胸膜侵犯的一个指标。
Clin Respir J. 2018 Mar;12(3):1011-1016. doi: 10.1111/crj.12619. Epub 2017 Mar 15.
4
Correlation between FDG-PET/CT findings and solid type non-small cell cancer prognostic factors: are there differences between adenocarcinoma and squamous cell carcinoma?氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG-PET/CT)结果与实性非小细胞癌预后因素之间的相关性:腺癌和鳞状细胞癌之间存在差异吗?
Ann Nucl Med. 2015 Dec;29(10):897-905. doi: 10.1007/s12149-015-1025-z. Epub 2015 Sep 5.
5
The role of computed tomography in assessing pleural malignancy prior to thoracoscopy.
Curr Opin Pulm Med. 2015 Jul;21(4):368-71. doi: 10.1097/MCP.0000000000000175.
6
Positron Emission Tomography/Computed Tomography for the Pleural Staging of Malignant Pleural Mesothelioma: How Accurate Is It?正电子发射断层扫描/计算机断层扫描用于恶性胸膜间皮瘤的胸膜分期:其准确性如何?
Respiration. 2015;89(6):558-64. doi: 10.1159/000381922. Epub 2015 May 8.
7
Clinical features and survival of lung cancer patients with pleural effusions.伴有胸腔积液的肺癌患者的临床特征与生存情况
Respirology. 2015 May;20(4):654-9. doi: 10.1111/resp.12496. Epub 2015 Feb 23.
8
Role of CT in assessing pleural malignancy prior to thoracoscopy.CT 在胸腔镜检查前评估胸膜恶性肿瘤中的作用。
Thorax. 2015 Feb;70(2):192-3. doi: 10.1136/thoraxjnl-2014-206054. Epub 2014 Jul 30.
9
Prognostic factors in patients presenting with pleural effusion revealing malignancy.表现为胸腔积液且确诊为恶性肿瘤患者的预后因素。
Respiration. 2014;87(4):311-6. doi: 10.1159/000356764. Epub 2014 Jan 22.
10
Etiology of pleural effusions: analysis of more than 3,000 consecutive thoracenteses.胸腔积液的病因:对连续3000多例胸腔穿刺术的分析
Arch Bronconeumol. 2014 May;50(5):161-5. doi: 10.1016/j.arbres.2013.11.007. Epub 2013 Dec 20.

肺癌所致恶性胸腔积液的细胞学、胸部计算机断层扫描及正电子发射断层扫描结果比较

Comparison of cytology, chest computed and positron emission tomography findings in malignant pleural effusion from lung cancer.

作者信息

Brun Clement, Gay Pierre, Cottier Michele, Karpathiou Georgia, Patoir Arnaud, Tiffet Oliviet, Barral Fabrice-Guy, Vergnon Jean-Michel, Froudarakis Marios E

机构信息

Departments of Pneumonology and Thoracic Oncology, University Hospital of Saint-Etienne, Saint-Priest-en-Jarez, France.

Departments of Cytology, University Hospital of Saint-Etienne, Saint-Priest-en-Jarez, France.

出版信息

J Thorac Dis. 2018 Dec;10(12):6903-6911. doi: 10.21037/jtd.2018.11.127.

DOI:10.21037/jtd.2018.11.127
PMID:30746236
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6344746/
Abstract

BACKGROUND

Malignant pleural effusion (MPE) is a common medical problem in lung cancer (LC). Pleural fluid cytology (PFC), chest computed tomography (CCT) and positron emission tomography (PET) findings are helpful as first line approach. The objectives of this study were to evaluate whether there is a correlation between PFC, CCT and PET in patients with MPE due to LC.

METHODS

We selected patients from our electronic files. Data of PFC, pleural biopsy (PB), CCT and PET have been recorded and analyzed.

RESULTS

A total of 101 consecutive patients (66 males, 65.3%) with a mean age of 66.2±31 years were selected. Types of LC were adenocarcinoma in 71 patients (70.2%), squamous in 13 (12.8%), small-cell in 12 (11.8%) and large cell in 5 (4.9%). CCT showed nodules in 6 (5.9%), pleural thickening in 8 (7.9%) and both in 17 (16.8%) patients. PFC was positive in 55/91 thoracentesis (60.4%) and 32/52 thoracoscopy (61.5%), while PB in 38/40 performed (95%). PET fixation was found in 32/47 (68%) patients who had MPE at diagnosis. When we associate PFC to CCT and PET findings, the yield in our study becomes 90%. No correlation was observed between CCT findings and PFC (P=0.62) between PFC and PET fixation (P=0.63) or between CCT and PET (P=0.06).

CONCLUSIONS

In our cohort of LC patients with MPE, we observed a high sensitivity for PFC, while in most of the cases no findings were observed in CCT. PET had a relative low sensitivity. However, when all 3 methods were combined the yield was 90%.

摘要

背景

恶性胸腔积液(MPE)是肺癌(LC)常见的医学问题。胸水细胞学检查(PFC)、胸部计算机断层扫描(CCT)和正电子发射断层扫描(PET)结果有助于作为一线检查方法。本研究的目的是评估因肺癌导致的恶性胸腔积液患者的胸水细胞学检查、胸部计算机断层扫描和正电子发射断层扫描之间是否存在相关性。

方法

我们从电子病历中选取患者。记录并分析了胸水细胞学检查、胸膜活检(PB)、胸部计算机断层扫描和正电子发射断层扫描的数据。

结果

共选取了101例连续患者(66例男性,占65.3%),平均年龄为66.2±31岁。肺癌类型为腺癌71例(70.2%),鳞癌13例(12.8%),小细胞癌12例(11.8%),大细胞癌5例(4.9%)。胸部计算机断层扫描显示6例(5.9%)有结节,8例(7.9%)有胸膜增厚,17例(16.8%)两者皆有。胸水细胞学检查在91例胸腔穿刺术中55例阳性(60.4%),在52例胸腔镜检查中32例阳性(61.5%),而胸膜活检在40例检查中38例阳性(95%)。在诊断时患有恶性胸腔积液的47例患者中,32例(68%)发现有PET固定。当我们将胸水细胞学检查结果与胸部计算机断层扫描和正电子发射断层扫描结果相关联时,本研究中的检出率为90%。未观察到胸部计算机断层扫描结果与胸水细胞学检查之间存在相关性(P=0.62),胸水细胞学检查与PET固定之间存在相关性(P=0.63),或胸部计算机断层扫描与PET之间存在相关性(P=0.06)。

结论

在我们这组患有恶性胸腔积液的肺癌患者中,我们观察到胸水细胞学检查具有较高的敏感性,而在大多数病例中胸部计算机断层扫描未发现异常。PET的敏感性相对较低。然而,当将这三种方法结合使用时,检出率为90%。